Argenx Se (ARGX) Net Margin (2016 - 2026)
Argenx Se's (ARGX) quarterly Net Margin came in at 30.33% in Q2 2026, up 447.0% YoY from 5.55% in Q2 2025, and up 7.58% on a QoQ basis from 28.2% in Q1 2026.
Argenx Se (ARGX) Net Margin (2016 - 2026) Analysis & Trends
Argenx Se (ARGX) has 11 years of Net Margin data on file, last reported at 30.33% in Q2 2026.
- Quarterly Net Margin rose 447.0% year-over-year to 30.33% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 32.57% (down 942.0% YoY) and the FY2025 annual result came in at 30.41%, down 658.0% from the prior year.
- Net Margin rose to 30.33% in Q2 2026, from 28.2% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 1073.51% in Q1 2022 to a low of 178.97% in Q3 2022.
- A 5-year average of 84.0% and a median of 24.07% in 2022 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin jumped 110012 bps — and 2023, when it slumped 106026 bps.
- Tracing ARGX's Net Margin over 5 years: stood at 22.27% in 2022, then advanced by 19 bps to 26.49% in 2023, then soared by 297 bps to 105.05% in 2024, then slumped by 61 bps to 41.45% in 2025, then retreated by 27 bps to 30.33% in 2026.
- The last three Net Margin figures came in at 30.33% (Q2 2026), 28.2% (Q1 2026), and 41.45% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -20,152.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.33% |
| Mar 31, 2026 | 28.20% |
| Dec 31, 2025 | 41.45% |
| Sep 30, 2025 | 30.55% |
| Jun 30, 2025 | 25.87% |
| Mar 31, 2025 | 21.39% |
| Dec 31, 2024 | 105.05% |
| Sep 30, 2024 | 15.95% |
| Jun 30, 2024 | 6.09% |
| Mar 31, 2024 | -15.47% |
| Dec 31, 2023 | 26.49% |
| Sep 30, 2023 | 22.07% |
| Jun 30, 2023 | -35.04% |
| Mar 31, 2023 | 13.24% |
| Dec 31, 2022 | 22.27% |
| Sep 30, 2022 | -178.97% |
| Jun 30, 2022 | 278.95% |
| Mar 31, 2022 | 1,073.51% |
| Dec 31, 2021 | -913.91% |
| Sep 30, 2021 | -0.03% |